ADVERTISEMENT:

 

Leopards’ fast forward, Phathutshedzo Mahwasane.  

Diski Leopards and City in Limpopo derby

 

The affiliates of the Multichoice Diski Challenge League will play their second-last league matches this weekend.

The league’s milk cow, Black Leopards FC, will play their second consecutive league match at home. This after they hosted the Durban side, Lamontville Golden Arrows, at the Thohoyandou Stadium last Sunday. Lidoda Duvha lost 0-3 to the Kwazulu Natal side, much to the fans’ disappointment.

The million-dollar question now is whether Black Leopards will manage to rise to the occasion and put a smile on the faces for their supporters when they entertain Polokwane City at the same venue tomorrow morning (Saturday), starting at 10:00.

Should they manage to collect the maximum points at the expense of City tomorrow, Lidoda Duvha will possibly move two steps up the on the log, depending on how the other two teams that are also fighting for survival, Maritzburg United and Chippa United, will perform in their matches.

Leopards will pin their hopes for goals on players such as Junior Letwaba, Phathutshedzo Mahwasane, Tshepang Moremedi and Tiklas Thutlwa.

In the two matches that will be staged at the King Zwelithini Stadium in Durban, Golden Arrows will host Mamelodi Sundowns while Cape Town City will play against Kaizer Chiefs.

The other fixtures are SuperSport United vs Bidvest Wits, Highlands Park vs Chippa United, Baroka vs Bloemfontein Celtic, Maritzburg United vs Amazulu and Free State Stars vs Orlando Pirates.

Sport - Date: 01 February 2019

Recent Articles

Search for a story:

 
 

ADVERTISEMENT

 

Frank Mavhungu

Frank is a Human Resources Manager at the Department of Public Works in Limpopo. He is the longest serving correspondent of the Mirror, having joined us at the end of 1990.  He mainly writes sports reports and resides at Tsianda Village. In 2004, Frank won the National Castle League Award, an award for the best reporter in the SAB league in South Africa.

Email:

ADVERTISEMENT: